Literature DB >> 782994

The comparative effects of barbituric acid phenobarbital on blood glucose and insulin secretion in mice.

J H Mennear, C Schonwalder, E T Yau.   

Abstract

The effects of barbituric acid and phenobarbital upon carbohydrate metabolism in mice were compared. An intraperitoneal dose of 100 mg/kg of barbituric acid increased blood glucose concentrations during an intravenous glucose tolerance test, but did not alter the rate of glucose disappearance from the blood. Barbituric acid also antagonized the hypoglycemic effect of intravenously administered tolbutamide. The same dose of phenobarbital had no effect. An in vitro concentration of 100 mug/ml of barbituric acid decreased the responsiveness of isolated mouse pancreatic islets to glucose stimulation (3.0 mg/ml D-glucose). Again phenobarbital, 100 mug/ml, was without effect. The structural similarities between barbituric acid, tolbutamide and alloxan suggest that the effects observed in these experiments might reflect a competition for binding to reactive sites on or within the pancreatic B-cell.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 782994     DOI: 10.1007/bf00422094

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  16 in total

1.  PRODUCTION OF TEMPORARY PROLONGED HYPERGLYCEMIA BY THE ADMINISTRATION OF GLUCOSE WITH BARBITURATES AND SULFAPYRAZINE.

Authors:  C D STEVENS; W HERZOG; M E TURNER
Journal:  J Pharmacol Exp Ther       Date:  1963-09       Impact factor: 4.030

2.  Effect of barbituric acid on alloxan diabetes in rats and dogs.

Authors:  C MARTINEZ
Journal:  Am J Physiol       Date:  1955-08

3.  Alloxan studies; the action of alloxan homologues and related compounds.

Authors:  G BRUCKMANN; E WERTHEIMER
Journal:  J Biol Chem       Date:  1947-04       Impact factor: 5.157

4.  [On 2-benzolsulfonylamino-5(beta-methoxy-ethoxy)-pyrimidine (glycodiazine. V. In vitro and in vivo experiments on the action of phenylethylbarbituric acid (Luminal) on the metabolism and blood sugar reducing effect of glycodiazine].

Authors:  E Gerhards; K H Kolb; P E Schulze
Journal:  Naunyn Schmiedebergs Arch Pharmakol Exp Pathol       Date:  1966

5.  Interactions between diphenylhydantoin and tolbutamide in mice.

Authors:  J H Mennear; T A Gossel
Journal:  Toxicol Appl Pharmacol       Date:  1973-02       Impact factor: 4.219

6.  Studies on the protective effect of diphenylhydantoin against alloxan diabetes in mice.

Authors:  M Esposito-Avella; J H Mennear
Journal:  Proc Soc Exp Biol Med       Date:  1973-01

7.  Blood sugar changes in neonatal hyperbilirubinaemia and phenobarbitone therapy.

Authors:  C Y Yeung
Journal:  Arch Dis Child       Date:  1972-04       Impact factor: 3.791

8.  The influence of phenobarbital on the glycogen concentration of rat liver.

Authors:  I Japundzić; M Japundzić; B Knezević; J Mimić-Oka
Journal:  Experientia       Date:  1969-05-15

9.  Neurotropic drugs, electroshock and carbohydrate metabolism in the rat.

Authors:  T Satoh; T Iwamoto
Journal:  Biochem Pharmacol       Date:  1966-03       Impact factor: 5.858

10.  The in vitro inhibition of insulin secretion by diphenylhydantoin.

Authors:  J S Kizer; M Vargas-Gordon; K Brendel; R Bressler
Journal:  J Clin Invest       Date:  1970-10       Impact factor: 14.808

View more
  1 in total

1.  Barbiturates inhibit ATP-K+ channels and voltage-activated currents in CRI-G1 insulin-secreting cells.

Authors:  R Z Kozlowski; M L Ashford
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.